Identification of Drug-Disease Associations by Using Multiple Drug and Disease Networks

被引:66
作者
Yang, Ying [1 ]
Chen, Lei [1 ]
机构
[1] Shanghai Maritime Univ, Coll Informat Engn, Shanghai 201306, Peoples R China
关键词
Drug repositioning; drug-disease association; network embedding method; random forest; mashup; classic classifi-; cation algorithm; RANDOM-WALK; PRIORITIZATION; INTEGRATION;
D O I
10.2174/1574893616666210825115406
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Drug repositioning is a new research area in drug development. It aims to discover novel therapeutic uses of existing drugs. It could accelerate the process of designing novel drugs for some diseases and considerably decrease the cost. The traditional method to determine novel therapeutic uses of an existing drug is quite laborious. It is alternative to design computational methods to overcome such defect. Objective: This study aims to propose a novel model for the identification of drug-disease associations. Methods: Twelve drug networks and three disease networks were built, which were fed into a powerful network-embedding algorithm called Mashup to produce informative drug and disease features. These features were combined to represent each drug-disease association. Classic classification algorithm, random forest, was used to build the model. Results: Tenfold cross-validation results indicated that the MCC, AUROC, and AUPR were 0.7156, 0.9280, and 0.9191, respectively. Conclusion: The proposed model showed good performance. Some tests indicated that a small dimension of drug features and a large dimension of disease features were beneficial for constructing the model. Moreover, the model was quite robust even if some drug or disease properties were not available.
引用
收藏
页码:48 / 59
页数:12
相关论文
共 62 条
[1]  
[Anonymous], 2005, Data Mining-Pratical Machine Learning Tools and Techniques
[2]  
[Anonymous], 2021, IEEE Trans. Broadcast.
[3]   Network medicine: a network-based approach to human disease [J].
Barabasi, Albert-Laszlo ;
Gulbahce, Natali ;
Loscalzo, Joseph .
NATURE REVIEWS GENETICS, 2011, 12 (01) :56-68
[4]   Identify Key Sequence Features to Improve CRISPR sgRNA Efficacy [J].
Chen, Lei ;
Wang, Shaopeng ;
Zhang, Yu-Hang ;
Li, Jiarui ;
Xing, Zhi-Hao ;
Yang, Jialiang ;
Huang, Tao ;
Cai, Yu-Dong .
IEEE ACCESS, 2017, 5 :26582-26590
[5]   Systematic Evaluation of Drug-Disease Relationships to Identify Leads for Novel Drug Uses [J].
Chiang, A. P. ;
Butte, A. J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (05) :507-510
[6]   Compact Integration of Multi-Network Topology for Functional Analysis of Genes [J].
Cho, Hyunghoon ;
Berger, Bonnie ;
Peng, Jian .
CELL SYSTEMS, 2016, 3 (06) :540-+
[7]   NEAREST NEIGHBOR PATTERN CLASSIFICATION [J].
COVER, TM ;
HART, PE .
IEEE TRANSACTIONS ON INFORMATION THEORY, 1967, 13 (01) :21-+
[8]   The computational prediction of drug-disease interactions using the dual-network L2,1-CMF method [J].
Cui, Zhen ;
Gao, Ying-Lian ;
Liu, Jin-Xing ;
Wang, Juan ;
Shang, Junliang ;
Dai, Ling-Yun .
BMC BIOINFORMATICS, 2019, 20 (1)
[9]   Matrix Factorization-Based Prediction of Novel Drug Indications by Integrating Genomic Space [J].
Dai, Wen ;
Liu, Xi ;
Gao, Yibo ;
Chen, Lin ;
Song, Jianglong ;
Chen, Di ;
Gao, Kuo ;
Jiang, Yongshi ;
Yang, Yiping ;
Chen, Jianxin ;
Lu, Peng .
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2015, 2015
[10]   Comparative Toxicogenomics Database (CTD): update 2021 [J].
Davis, Allan Peter ;
Grondin, Cynthia J. ;
Johnson, Robin J. ;
Sciaky, Daniela ;
Wiegers, Jolene ;
Wiegers, Thomas C. ;
Mattingly, Carolyn J. .
NUCLEIC ACIDS RESEARCH, 2021, 49 (D1) :D1138-D1143